Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 4,381 shares at $45.01 ($197K) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Scheduled sale ($197k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 2,060 | $93K | 47.0% |
| 2 | $45.01 | 2,060 | $93K | 47.0% |
| 3 | $46.00 | 261 | $12K | 6.1% |
| Total | $45.07 avg | 4,381 | $197K | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |
| DYN | SELL | 2024-02-28 | $10K | — | Filing → |